DAVID DILDINE MD NPI 1508094772

NPI Details

David Dildine, MD is a family medicine in Norwood, MA with 17 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. David Dildine, MD NPI is 1508094772. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Graduation Year:2009

The provider's business location address is:

1177 BOSTON PROVIDENCE TPKE
NORWOOD, MA
ZIP 02062-019
Phone: (781) 329-1400

The NPI 1508094772 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Urinalysis, manual test (HCPCS:81002)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Bacterial colony count, urine (HCPCS:87086)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Screening test for pathogenic organisms (HCPCS:87081)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Lipase (fat enzyme) level (HCPCS:83690)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Automated urinalysis test (HCPCS:81003)

The enumeration date for this NPI number is 6/26/2009 and was last updated on 1/7/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: